Leflunomide and Malononitrilamides
- 1 May 1997
- journal article
- review article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 313 (5) , 289-301
- https://doi.org/10.1097/00000441-199705000-00008
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- REGULATION OF B CELL FUNCTION BY THE IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1Transplantation, 1996
- PHARMACOLOGICALLY INDUCED REGRESSION OF CHRONIC TRANSPLANT REJECTIONTransplantation, 1995
- Blood Distribution and Single-Dose Pharmacokinetics of LeflunomideTherapeutic Drug Monitoring, 1995
- Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory CompoundJournal of Biological Chemistry, 1995
- Leflunomide: Inhibition of S-antigen induced autoimmune uveitis in Lewis ratsInflammation Research, 1994
- Inhibition of Interleukin 2 (IL-2)-stimulated tyrosine kinase activity by leflunomideInflammation Research, 1994
- Suppression of autoimmune responses and inflammatory events by leflunomide in an animal model for rheumatoid arthritisInflammation Research, 1994
- Effect of leflunomide on constitutive and inducible pathways of cellular eicosanoid generationInflammation Research, 1994
- LEFLUNOMIDE IN EXPERIMENTAL TRANSPLANTATIONTransplantation, 1994
- Effects of leflunomide (HWA 486) on expression of lymphocyte activation markersInflammation Research, 1993